• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 61 Show All Page 1 of 2
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1126
Calcium acetate Pending
  1108
Lactiplantibacillus plantarum strain MCC 0537 Aug 16, 2023 FDA has no questions (In PDF) (290 kB)
  1097
Maltogenic alpha-amylase enzyme preparation produced by Escherichia coli expressing a gene encoding a maltogenic alpha-amylase from Geobacillus stearothermophilus Pending
  1021
Transglutaminase enzyme preparation produced by Streptomyces mobaraensis strain M2020197 Nov 3, 2022 FDA has no questions (in PDF) (395 kB)
  991
Chitosanase enzyme preparation produced by Bacillus subtilis Aug 31, 2022 FDA has no questions (in PDF) (225 kB)
  990
Short-chain fructooligosaccharides Oct 8, 2021 FDA has no questions (in PDF) (109 kB)
  971
Bacillus clausii strain 088AE spore preparation Mar 3, 2022 FDA has no questions (in PDF) (150 kB)
  956
Bacillus subtilis ATCC SD-7280 Aug 18, 2021 FDA has no questions (in PDF) (131 kB)
  949
Bacillus coagulans strain DSM 17654 spore preparation Jan 7, 2021 FDA has no questions (in PDF)
  948
Enzyme-treated pea protein Sep 9, 2021 FDA has no questions (in PDF) (151 kB)
  910
Thaumatin II Sep 9, 2020 FDA has no questions (in PDF) (541 kB)
  890
Corn oil derived from distillers grains Dec 23, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (189 kB)
  887
Menaquinone-7 Jun 12, 2020 FDA has no questions (in PDF) (472 kB)
  834
Preparation containing bacterial phages specific to shiga-toxin producing Escherichia coli Nov 8, 2019 FDA has no questions (in PDF) (91 kB) Jan 12, 2024
  797
Fructooligosaccharides Nov 15, 2018 FDA has no questions (in PDF) (454 kB)
  788
Pea protein concentrate Oct 12, 2018 FDA has no questions (in PDF) (249 kB)
  783
Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger Dec 20, 2018 FDA has no questions (in PDF) (75 kB)
  738
Thaumatin Apr 18, 2018 FDA has no questions (in PDF) (77 kB)
  712
Calcium acetate Feb 5, 2018 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
  650
2'-O-fucosyllactose Nov 23, 2016 FDA has no questions Sep 11, 2020
Sep 9, 2020
  604
Baker's Yeast (Saccharomyces cerevisiae) expressing asparaginase II Apr 27, 2016 FDA has no questions
  588
Zeaxanthin from Capsicum annum (paprika) Feb 29, 2016 FDA has no questions; some uses may require a color additive listing
  546
2'-O-fucosyllactose Sep 16, 2015 FDA has no questions
  532
Complexation products of sodium tartrates with iron (III) chloride Feb 6, 2015 FDA has no questions; some uses may require a color additive listing
  512
High purity Rebaudioside M Oct 24, 2014 FDA has no questions
  511
Citric acid esters of mono- and diglycerides Nov 10, 2014 FDA has no questions
  510
Acid lactase from Aspergillus oryzae expressed in Aspergillus niger Sep 29, 2014 FDA has no questions
  508
Salts from dried mineral water (65% NaCl) Sep 24, 2014 At the notifier's request, FDA ceased to evaluate this notice
  505
Phosphodiesterase I enzyme preparation from Leptographium procerum Aug 12, 2014 FDA has no questions
  504
Milk protein concentrate and milk protein isolate
   (Resubmission of GRN 444)
Nov 21, 2014 FDA has no questions
  502
Lactobacillus acidophilus La-14 Aug 19, 2014 FDA has no questions
  501
L-theanine (chemically synthesized) Jul 30, 2014 FDA has no questions
  499
Magnesium L-threonate hydrate Sep 3, 2014 FDA has no questions
  495
Galacto-oligosaccharides May 30, 2014 FDA has no questions
  489
Galacto-oligosaccharides May 22, 2014 FDA has no questions
  485
Beta-galactosidase enzyme preparation Apr 15, 2014 FDA has no questions
  483
Aqueous extract of Emblica officinalis
   (Resubmission of GRN 322)
Apr 17, 2014 FDA has no questions
  481
Meso-zeaxanthin Apr 11, 2014 FDA has no questions; some uses may require a color additive listing
  475
Citrus fruit extract May 8, 2014 FDA has no questions
  471
Annatto seed extract May 19, 2014 FDA has no questions; some uses may require a color additive listing
  464
Cow's milk-derived lactoferrin Feb 18, 2014 FDA has no questions
  444
Milk protein concentrate and milk protein isolate Mar 18, 2013 At the notifier's request, FDA ceased to evaluate this notice
  504
  439
Iron complex of tartaric acid Nov 9, 2012 At the notifier's request, FDA ceased to evaluate this notice
  423
Cow's milk-derived lactoferrin May 2, 2012 At the notifier's request, FDA ceased to evaluate this notice
  400
D-psicose Jun 18, 2012 FDA has no questions
  385
Lutein Dec 16, 2011 FDA has no questions; some uses may require a color additive listing
  345
Carboxypeptidase enzyme preparation from modified Aspergillus niger Dec 22, 2010 FDA has no questions
  342
Oat hull fiber Dec 23, 2010 FDA has no questions
  341
Quercetin Nov 22, 2010 FDA has no questions; some uses may require a color additive listing
  319
Micro-algal oil Ulkenia sp. SAM2179
   (Resubmission of GRN 160)
Aug 4, 2010 FDA has no questions; some uses may require a color additive listing

Show All 

jump to page of 2 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-